These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28610898)

  • 21. Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Gariepy AM; Duffy JY; Xu X
    Obstet Gynecol; 2015 Jul; 126(1):47-55. PubMed ID: 26241255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
    N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the contraceptive implant on maternal and neonatal morbidity and mortality in rural Papua New Guinea: a retrospective observational cohort study.
    Gupta S; Ramsay P; Mola G; McGeechan K; Bolnga J; Kelly-Hanku A; Black KI
    Contraception; 2019 Jul; 100(1):42-47. PubMed ID: 30898659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactogenesis and breastfeeding after immediate vs delayed birth-hospitalization insertion of etonogestrel contraceptive implant: a noninferiority trial.
    Henkel A; Lerma K; Reyes G; Gutow H; Shaw JG; Shaw KA
    Am J Obstet Gynecol; 2023 Jan; 228(1):55.e1-55.e9. PubMed ID: 35964661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
    Sivin I; Lähteenmäki P; Ranta S; Darney P; Klaisle C; Wan L; Mishell DR; Lacarra M; Viegas OA; Bilhareus P; Koetsawang S; Piya-Anant M; Diaz S; Pavez M; Alvarez F; Brache V; LaGuardia K; Nash H; Stern J
    Contraception; 1997 Feb; 55(2):81-5. PubMed ID: 9071516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants.
    Abdulla KA; Elwan SI; Salem HS; Shaaban MM
    Contraception; 1985 Sep; 32(3):261-6. PubMed ID: 3936675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised clinical trial to assess satisfaction with the levonorgestrel- releasing intrauterine system inserted at caesarean section compared to postpartum placement.
    Braniff K; Gomez E; Muller R
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):279-83. PubMed ID: 26053465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of contraceptive implants at 12 months in women who intended to undergo immediate versus delayed postpartum insertion following high-risk pregnancy.
    Waidee T; Kaewrudee S; Wattanakamolchai P; Sothornwit J
    Obstet Gynecol Sci; 2023 May; 66(3):241-251. PubMed ID: 37062533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provision of family planning vouchers and early initiation of postpartum contraceptive use among women living with HIV in southwestern Uganda: A randomized controlled trial.
    Atukunda EC; Mugyenyi GR; Obua C; Atuhumuza EB; Lukyamuzi EJ; Kaida A; Agaba AG; Matthews LT
    PLoS Med; 2019 Jun; 16(6):e1002832. PubMed ID: 31226123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration.
    Chen BA; Reeves MF; Creinin MD; Schwarz EB
    Contraception; 2011 Nov; 84(5):499-504. PubMed ID: 22018124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers.
    Stevens-Simon C; Kelly L
    Arch Pediatr Adolesc Med; 1998 Sep; 152(9):893-8. PubMed ID: 9743036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
    Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
    Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postpartum contraceptive counseling for first-time adolescent mothers: a randomized controlled trial.
    Frarey A; Gurney EP; Sober S; Whittaker PG; Schreiber CA
    Arch Gynecol Obstet; 2019 Feb; 299(2):361-369. PubMed ID: 30470924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of an educational script on postpartum contraceptive use: a randomized controlled trial.
    Tang JH; Dominik RC; Zerden ML; Verbiest SB; Brody SC; Stuart GS
    Contraception; 2014 Aug; 90(2):162-7. PubMed ID: 24833047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
    Gupta S; Mola G; Ramsay P; Jenkins G; Stein W; Bolnga J; Black K
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):213-218. PubMed ID: 28401563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracesarean insertion of the Copper T380A versus 6 weeks postcesarean: a randomized clinical trial.
    Lester F; Kakaire O; Byamugisha J; Averbach S; Fortin J; Maurer R; Goldberg A
    Contraception; 2015 Mar; 91(3):198-203. PubMed ID: 25499587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.